Delivery Order SPE2DB22D1017-SPE2DB24FG0DP
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,088.15 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Telmisartan 80 mg tablets in 30-count packages, with a completion date of February 28, 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,564,322,194 tablets of the drug telmisartan 40 mg. The $11,640.08 contract has an ultimate completion date of April 19, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
The U.S. Defense Logistics Agency (DLA) awarded a $6,593.82 Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets. This contract has a period of performance through September 19, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medications to support DLA Troop Support Medical's mission of supplying medical commodities to military treatment facilities and other government...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,589.63 contract is for the provision of 4,564,186,162 units of Telmisartan 80 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This is a $3,970.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,710,990 tablets of the drug Telmisartan 80 mg. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of essential medical...
The Defense Logistics Agency (DLA) awarded a $14,041.07 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a...
The Defense Logistics Agency (DLA) awarded a $1,105.65 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets, and has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $11,391.18 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit doses of 30s. This is an unset-aside firm fixed-price contract with an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office Division, is a major supplier of pharmaceutical products and...
This federal contract award, valued at $1,117.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,013,582 units of telmisartan 80 mg tablets in 30-count packages. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $21,853.43 to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,098,788 units of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count packages. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...